Rating scales are increasingly used as primary or secondary outcome measures in clinical studies in neurology.
They are therefore becoming the key dependent variables upon which decisions are made that influence patient care and guide future research. The adequacy of these decisions depends directly on the scientific quality of the rating scales, which is reflected by the increased application of rating scale science (psychometrics) in health outcomes measurement in neuroscience and increasing regulatory involvement by governing bodies such as the US Food and Drug Administration (FDA). 2, 3 However, the majority of clinical studies in neurology that use rating scales are currently inadequate. Two simple examples illustrate some of the key issues. Our research findings support the need for stringent quantitative and qualitative requirements for rating scales used in neurology; such scales must also be proved to be clinically meaningful and scientifically rigorous for valid interpretations of clinical studies. So, why is this not happening right now? There are two key problems. First, the numbers generated by most rating scales do not satisfy the scientific definition for measurements. Second, we do not really know what variables most rating scales are measuring. This article addresses these two problems by introducing some of the key issues in current rating scale research methodology. For readers who would like to learn more, we expand on these ideas in a recent review 1 and forthcoming monograph. 
Rating Scales as Measurement Instruments-

Some Basic Principles
Before anything can be measured, the variable along which the measurements are to be made must be identified and marked out. 6 Common examples are rulers and weighing scales, which mark out length in centimeters (or inches) and weight in grams (or ounces), respectively.
They highlight three central features of all measurements, as illustrated in Figure 1 : first, instruments are constructed to make measurements; second, the attribute being measured can be marked out as a line, or continuum, onto which the measurements can be located; and third, the markings on the continuum represent the units of measurement.
Variables such as height and weight can be measured directly.
Other variables-such as disability, cognitive functioning, and quality of an example of a multi-item scale and how it represents a mobility variable as a 'ruler' of a count up to 15 points. Typically, item scores are summed to give a single total score for each person (also called raw, summed, or scale score), which is taken to be a 'measure' of the variable quantified by the set of items.
It has long been recognized that single-item scales are scientifically weak, 17 while multi-item scales can be scientifically strong. However, the fact that a single value, derived from summing the scores from a set of items, is taken to be a 'measurement' invokes two fundamental requirements of multi-item rating scales: evidence that the values produced satisfy the scientific definition of measurements rather than simply being numerals, and evidence that the set of items maps out the variable it purports to measure. In reality, these requirements are rarely met.
Problem 1-Scales Do Not Generate Measurement
The first problem with rating scales is that the numbers they generate are not measurements in the scientific sense of the word. To understand this statement we need to consider the definition of measurement and the extent to which the numbers generated by scales meet that definition.
Measurement is defined as the quantitative comparison between two magnitudes of the same type, one of which is a standard unit, and in which the comparison is expressed as a numerical ratio. Figure 2 ). Although counting observations is the beginning of measurement, as all observations begin as ordinal if not nominal data, something must be done to turn counts into measurements. 22 This is because a fundamental requirement of the definition of 'measurement' is a constant unit. [22] [23] [24] [25] It is difficult to set up an argument against scale scores being ordinal in nature. However, a frequently asked question is: does this really matter in practice? This question arises from the logic that the clinical descriptors of the different levels of the Ashworth scale, for example, are ordered to map out progressive spasticity, and the logic that producing clinical descriptors representing near-equal intervals would be unrealistic.
Therefore, why not simply assign sequential scores? The problem arises when the data are analyzed. The importance of a constant unit is that the numerical meaning of numbers is maintained when they are added, subtracted, divided, or multiplied (i.e. subjected to statistical analysis). 22, 25 By simply assigning sequential integer scores we are implying that there is a constant unit, and by analyzing the data statistically and making clinical inferences we are believing it. This is a potentially very dangerous practice. Less
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A shows that a variable, here multiple sclerosis (MS) disability, can be represented as a line, or continuum, ranging from less disability to more disability. B shows a 'mark' that represents the location of a person on the variable and indicates the amount of disability that person has. C illustrates that to 'measure' a person's MS disability, the disability continuum must have marks that separate it into units. D shows a 'ruler' with equal interval units-the prototype of all measurements.
It is difficult to set up an argument This simple theory with its associated assumptions expanded to form the methods for testing reliability and validity known as traditional psychometric methods. 27 However, the fact that these methods are derived from CTT means that their appropriateness requires that the theory and assumptions of CTT are supported by the data. If these requirements are not met, the conclusions arising from the data analysis may be incorrect. This is where the problems lie: CTT is a theory that cannot be tested, verified, or-more importantly-falsified in any data set, 28 as T and E cannot be determined in a way that enables evaluation of their accuracy. 29, 30 This has four important implications. First, untestable measurement theories are, by definition, weak theories enabling only weak inferences about rating scale performance and the measurements of people.
Second, theories that cannot be challenged are easily satisfied by data sets. 29, 30 Third, as T scores cannot be estimated from O scores in a way that enables their accuracy to be checked, only the observed data Fully ambulatory without aid, up and about much of the day, able to work a full day, may otherwise have some limitation of full activity or require minimal assistance, characterized by relatively severe disability (1 x FS = 4, others 0 or 1), able to walk without aid or rest for some 300 meters (975ft) 5.0
Ambulatory without aid or rest for about 200 meters (650ft), disability severe enough to impair full daily activities (e.g. able to work full day without special provisions; 1 x FS = 5, others 0 or 1) 5.5
Ambulatory without aid or rest for about 100 meters (325ft), disability severe enough to impair full daily activities (1 x FS = 5, others 0 or 1) 6.0
Intermittent or constant unilateral assistance (cane, crutch, brace) required to walk about 100 meters (325ft) with or without resting (>2 x FS = 3+) 6.5
Constant bilateral assistance (canes, crutches, braces) required to walk about 20 meters (65ft; >2 x FS = 3+) 7.0 Unable to walk beyond about 5 meters (16ft) even with aid, essentially restricted to wheelchair, wheels self in standard wheelchair a full day and transfers alone, up and about in wheelchair some 12 hours a day (>1 FS = 4+, very rarely pyramidal grade 5 alone) 7.5
Unable to take more than a few steps, restricted to wheelchair, may need aid in transfers, wheels self but cannot carry on in standard wheelchair a full day, may require motorized wheelchair (>1 x FS = 4+) 8.0
Essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many self-care functions, generally has effective use of arms (FS = 4+ in several systems) 8.5
Essentially restricted to bed for much of the day, has some effective use of arm(s), retains some self-care functions (FS = 4+ in several systems) 9.0 Helpless bed patient, can communicate and eat (usual FS ≥4) 9. 5 Totally helpless bed patient, unable to communicate effectively or eat/swallow (FS = 4+) 10 Death due to MS FS = functional system; MS = multiple sclerosis. There is no doubt that both IRT and Rasch measurement offer substantial advantages over CTT for neurology research. Other advantages, beyond the scope of this article, include item banking, scale equating, computerized scale administration, and the handling of missing data. As such, clinicians should be actively looking to apply these methods in the future. However, which approach is better, and does it matter which approach is used?
Figure 2: The Expanded Disability Status Scale and How It Maps Out a 'Ruler' for Measuring the Impact of Multiple Sclerosis
The answer to both questions depends on which central philosophy is followed, as this divides proponents of IRT and Rasch measurement. As IRT prioritizes the observed data, it sees the Rasch perspective of using only one model as too restrictive and the 'selection' of data to meet that model as threatening to content validity. 38, 39 As Rasch measurement prioritizes the mathematical model, it sees the process of modeling data as precluding the ability to achieve core requirements of measurement, too accepting of poor quality data, and threatening to construct validity. Not surprisingly, it has been suggested that IRT and Rasch measurement have irreconcilable differences, and the two groups have come into conflict regarding which approach is preferable.
40
Problem 2-Exactly What Do Scales Measure?
Pivotal clinical trials obviously require rating scales that measure the health constructs they purport to measure (i.e. are valid) and health constructs that are clinically meaningful and interpretable. Unfortunately, current methods of establishing rating scale validity rarely enable these goals to be confirmed. To appreciate this opinion, some scale basics must 
There is no doubt that both Item
Response Theory and Rasch measurement offer substantial advantages over Classical Test Theory for neurology research.
be recapped. When a set of items is used as a scale, a claim is being made that a construct is being measured. 41 Implicit to this claim is some theory of the construct being measured (a construct theory). 42 For example, the RMI (see Figure 3 ) uses a set of 15 items. It makes a claim that mobility is being measured. As such, there must be some theory of mobility underpinning the use of these specific 15 items. It follows that the aim of validity testing is to establish the extent to which a specific construct is being measured and, by implication, the extent to which the construct theory is supported.
Current methods for establishing scale validity cannot achieve these aims because they do not include formal methods for defining and testing construct theories. 42 While scales (e.g. the RMI) and the constructs they purport to measure (e.g. mobility) always have names, they are rarely underpinned by a theory of the construct being measured that has been deduced. Thus, there are rarely construct theories to test formally.
History has proved that proposing and challenging theories is central to scientific development. 43, 44 This situation seems surprising as explicit definitions of constructs would seem 42 Like their non-statistical counterparts, they have remained essentially unchallenged for decades.
Solution 2-Theory-referenced Measurement
Two things are needed to advance our understanding of precisely what scales measure: explicit theories of the constructs being measured, and explicit methods of testing those theories. Over the last 25 years, a number of groups have addressed these issues. 42, [56] [57] [58] [59] 60, 61 One group in particular has developed their ideas to an advanced level. 42, 56, 59 However, their work is largely inaccessible to clinicians as it concerns the measurement of reading ability. A review of that work is illuminating.
The central premise of this group's approach is a change in focus from studying people to studying items. 42 An example helps to make this idea tangible. The Lexile system is a scale for measuring people's reading ability.
The items of the scale are passages of text with different levels of readability Construct specification equations are developed by regression analysis of item locations (here text difficulty) on selected item characteristics (here word frequency and sentence length). They afford a test of fit between scalegenerated observations and theory. 56 In essence, the greater the proportion of variation in item location explained by the selected item characteristics, the greater the support for the proposed construct theory, the greater the evidence for scale validity, and the more clinically meaningful the interpretation of person locations. Moreover, construct specification equations allow different construct theories to be articulated and challenged, thus enabling dynamic interplay between theory and scale 42 and a thorough investigation of individual items to aid item development and selection.
So What Next?
There are three key steps neurologists can take right now to help improve the rating scales used in neurology. First, more neurologists need to be formally trained in rating scale methods to ensure that health measurement develops clinically meaningful scales. Second, awareness of the critical role played by rating scales must increase, thus neurologists who are also journal editors, reviewers, and involved with grant-giving bodies should build links, or have direct access to, people with expertise in rating scale development and evaluation. Third, neurologists already involved in rating scale research should begin to aspire to new methodologies, such as Rasch measurement and theory-referenced measurement.
We hope the arguments in this article have helped to illustrate some of the current problems and potential solutions in using rating scales in clinical studies of neurology. Although we have only touched upon the value of new psychometric methods and theory-referenced measurement, we feel that these new avenues have much to offer all neurological outcome measurement, state-of-the-art clinical trials, and, most importantly, the individual patients that neurologists treat. We hope that neurologists interested in conducting rating scale research will use this article as a springboard to finding out more about new developments in this rapidly growing area. ■
